Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Five9, Inc.FIVN · Entity 4346 | Director | May 20, 2026 | May 22, 2026 |
| MapLight Therapeutics, Inc.MPLT · Entity 5316 | Director | June 23, 2026 | June 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Five9, Inc.
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,411 |
Reported balance
After 2026-05-20 transaction · row 1
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 8,972 · Balance 20,411 |
MapLight Therapeutics, Inc.
Report date June 23, 2026 · Filed June 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Voting Common StockSEC Table I · non-derivative | Direct | 62,703 |
Reported balance
After 2026-06-23 transaction · row 1
1 source rowRow 1 · 2026-06-23 · Grant · Acquired 3,932 · Balance 62,703 F1: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. F2: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.64 · Expires 2036-06-22 | Direct | 14,902 |
Reported balance
After 2026-06-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-23 · Grant · Acquired 14,902 · Balance 14,902 F3: Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.
F2: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
F3: Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ForgeRock, Inc.
Report date August 23, 2023 · Filed August 25, 2023
Section 16 reporting ended · disclosed 2023-08-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-08-23 transaction · row 1
1 source rowRow 1 · 2023-08-23 · Disposition to issuer · Disposed 11,903 · Balance 0 F1: Represents shares of Class A common stock that were disposed of at the effective time (the "Effective Time") of the merger (the "Merger") of Project Fortress Merger Sub, Inc. by and into ForgeRock, Inc. (the "Issuer") pursuant to an Agreement and Plan of Merger, dated October 10, 2022, by and among the Issuer, Project Fortress Parent, LLC, and Project Fortress Merger Sub, Inc. (the "Merger Agreement"). F2: In connection with the Merger, these shares were cancelled and converted into the right to receive a cash payment per share of $23.25, without interest, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration"). |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.71 | Direct | 0 |
Reported balance
After 2023-08-23 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-08-23 · Disposition to issuer · Disposed 166,457 · Balance 0 F3: Pursuant to the terms of a stock option agreement between the Reporting Person and the Issuer, this option vested in full in connection with the Merger. At the Effective Time, this option was canceled and converted into the right to receive a cash payment equal to the difference between (a) the aggregate exercise price of this option and (b) the product of the Merger Consideration and the number of shares subject to this option. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of Class A common stock that were disposed of at the effective time (the "Effective Time") of the merger (the "Merger") of Project Fortress Merger Sub, Inc. by and into ForgeRock, Inc. (the "Issuer") pursuant to an Agreement and Plan of Merger, dated October 10, 2022, by and among the Issuer, Project Fortress Parent, LLC, and Project Fortress Merger Sub, Inc. (the "Merger Agreement").
F2: In connection with the Merger, these shares were cancelled and converted into the right to receive a cash payment per share of $23.25, without interest, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration").
F3: Pursuant to the terms of a stock option agreement between the Reporting Person and the Issuer, this option vested in full in connection with the Merger. At the Effective Time, this option was canceled and converted into the right to receive a cash payment equal to the difference between (a) the aggregate exercise price of this option and (b) the product of the Merger Consideration and the number of shares subject to this option.
Montes Archimedes Acquisition Corp
Report date September 30, 2021 · Filed October 04, 2021
Section 16 reporting ended · disclosed 2021-10-04. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 23, 2026 Filed Jun 25, 2026 21:52 UTC | MapLight Therapeutics, Inc. MPLT · Entity 5316 | GrantStock Option (right to buy) · Derivative | 14,902 | $0.00 Strike: $28.64 | $0.00 |
DisclosureSEC source: 0001826519-26-000002 · form4-06252026_090603.xml · derivative · entry 2 Walker Maria C · CIK 0001826519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,902 Underlying: Voting Common Stock · 14,902 shares Expires 2036-06-22 F3 · derivative.exercise_date: Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. Read SEC document |
| June 23, 2026 Filed Jun 25, 2026 21:52 UTC | MapLight Therapeutics, Inc. MPLT · Entity 5316 | GrantVoting Common Stock | 3,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001826519-26-000002 · form4-06252026_090603.xml · nonDerivative · entry 1 Walker Maria C · CIK 0001826519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,703 F1 · shares: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy. F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. Read SEC document |
| May 20, 2026 Filed May 22, 2026 21:52 UTC | Five9, Inc. FIVN · Entity 4346 | GrantCommon Stock | 8,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001288847-26-000096 · wk-form4_1779486750.xml · nonDerivative · entry 1 Walker Maria C · CIK 0001826519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,411 Read SEC document |
| October 27, 2025 Filed Oct 28, 2025 20:15 UTC | MapLight Therapeutics, Inc. MPLT · Entity 5316 | GrantEmployee Stock Option (right to buy) · Derivative | 25,604 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001826519-25-000008 · form4-10282025_041018.xml · derivative · entry 2 Walker Maria C · CIK 0001826519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,604 Underlying: Voting Common Stock · 25,604 shares Expires 2035-10-26 F3 · derivative.exercise_date: 1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| October 27, 2025 Filed Oct 28, 2025 20:15 UTC | MapLight Therapeutics, Inc. MPLT · Entity 5316 | GrantVoting Common Stock | 6,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001826519-25-000008 · form4-10282025_041018.xml · nonDerivative · entry 1 Walker Maria C · CIK 0001826519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,294 F1 · shares: Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date. F2 · price: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. Read SEC document |
| May 21, 2024 Filed May 22, 2024 21:23 UTC | Five9, Inc. FIVN · Entity 4346 | GrantCommon Stock | 3,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001288847-24-000087 · wk-form4_1716413010.xml · nonDerivative · entry 2 Walker Maria C · CIK 0001826519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,439 Read SEC document |
| May 21, 2024 Filed May 22, 2024 21:23 UTC | Five9, Inc. FIVN · Entity 4346 | GrantCommon Stock | 7,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001288847-24-000087 · wk-form4_1716413010.xml · nonDerivative · entry 1 Walker Maria C · CIK 0001826519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,626 Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 16:27 UTC | ForgeRock, Inc. FORG · Entity 15406 | Disposition to issuerStock Option (right to buy) · Derivative | 166,457 | $23.25 Strike: $4.71 | $3,870,125.25 |
DisclosureSEC source: 0001209191-23-047317 · doc4.xml · derivative · entry 2 Walker Maria C · CIK 0001826519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class B Common Stock · 166,457 shares Expires not disclosed F3 · derivative.exercise_date: Pursuant to the terms of a stock option agreement between the Reporting Person and the Issuer, this option vested in full in connection with the Merger. At the Effective Time, this option was canceled and converted into the right to receive a cash payment equal to the difference between (a) the aggregate exercise price of this option and (b) the product of the Merger Consideration and the number of shares subject to this option. F3 · derivative.expiration_date: Pursuant to the terms of a stock option agreement between the Reporting Person and the Issuer, this option vested in full in connection with the Merger. At the Effective Time, this option was canceled and converted into the right to receive a cash payment equal to the difference between (a) the aggregate exercise price of this option and (b) the product of the Merger Consideration and the number of shares subject to this option. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 16:27 UTC | ForgeRock, Inc. FORG · Entity 15406 | Disposition to issuerClass A Common Stock | 11,903 | $23.25 | $276,744.75 |
DisclosureSEC source: 0001209191-23-047317 · doc4.xml · nonDerivative · entry 1 Walker Maria C · CIK 0001826519 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Represents shares of Class A common stock that were disposed of at the effective time (the "Effective Time") of the merger (the "Merger") of Project Fortress Merger Sub, Inc. by and into ForgeRock, Inc. (the "Issuer") pursuant to an Agreement and Plan of Merger, dated October 10, 2022, by and among the Issuer, Project Fortress Parent, LLC, and Project Fortress Merger Sub, Inc. (the "Merger Agreement"). F2 · price: In connection with the Merger, these shares were cancelled and converted into the right to receive a cash payment per share of $23.25, without interest, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration"). Read SEC document |
| May 25, 2022 Filed May 27, 2022 17:12 UTC | ForgeRock, Inc. FORG · Entity 15406 | GrantClass A Common Stock | 2,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-032648 · doc4.xml · nonDerivative · entry 2 Walker Maria C · CIK 0001826519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,903 F1 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock of ForgeRock, Inc. (the "Issuer"), subject to the applicable vesting schedule and conditions of each RSU. F3 · shares: The reported securities represent RSUs. 25% of the RSUs will vest on each Quarterly Vesting Date (as defined below) following May 20, 2022, subject to the Reporting Person's continued service as a member of the board of directors of the Issuer (the "Board"), as a member of a committee of the Board, or as chairperson of a committee of the Board, as the case may be, through each applicable vesting date. A "Quarterly Vesting Date" is each of February 20, May 20, August 20 and November 20. Read SEC document |
| May 25, 2022 Filed May 27, 2022 17:12 UTC | ForgeRock, Inc. FORG · Entity 15406 | GrantClass A Common Stock | 9,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-032648 · doc4.xml · nonDerivative · entry 1 Walker Maria C · CIK 0001826519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,057 F1 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock of ForgeRock, Inc. (the "Issuer"), subject to the applicable vesting schedule and conditions of each RSU. F2 · shares: The reported securities represent RSUs. 100% of the RSUs will vest on the earlier of (i) May 25, 2023 and (ii) the day before the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 16:34 UTC | ForgeRock, Inc. FORG · Entity 15406 | OtherStock Option (right to buy) · Derivative | 166,457 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0001209191-21-057266 · doc4.xml · derivative · entry 2 Walker Maria C · CIK 0001826519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,457 Underlying: Class B Common Stock · 166,457 shares Expires 2029-11-14 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 (the "Reclassification"), each share of ForgeRock, Inc.'s (the "Issuer") common stock, par value $0.001 per share (the "Common Stock"), was automatically reclassified into one share of the Issuer's Class B common stock, par value $0.001 per share (the "Class B Common Stock"), immediately prior to the closing of the initial public offering (the "IPO") of the Issuer's Class A common stock, par value $0.001 per share (the "Class A Common Stock"). Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will, subject to certain conditions and exceptions, convert automatically into one share of Class A Common Stock upon any transfer. F2 · kind: Effective upon the occurrence of the Reclassification, all stock options outstanding under the Issuer's 2012 Equity Incentive Plan (the "2012 Plan") cover shares of Class B Common Stock. F1 · price: Pursuant to a reclassification exempt under Rule 16b-7 (the "Reclassification"), each share of ForgeRock, Inc.'s (the "Issuer") common stock, par value $0.001 per share (the "Common Stock"), was automatically reclassified into one share of the Issuer's Class B common stock, par value $0.001 per share (the "Class B Common Stock"), immediately prior to the closing of the initial public offering (the "IPO") of the Issuer's Class A common stock, par value $0.001 per share (the "Class A Common Stock"). Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will, subject to certain conditions and exceptions, convert automatically into one share of Class A Common Stock upon any transfer. F3 · derivative.exercise_date: Option granted under the Issuer's 2012 Plan. One forty-eighth (1/48th) of the shares subject to the option vest each month beginning on December 14, 2019, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 16:34 UTC | ForgeRock, Inc. FORG · Entity 15406 | OtherStock Option (right to buy) · Derivative | 166,457 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0001209191-21-057266 · doc4.xml · derivative · entry 1 Walker Maria C · CIK 0001826519 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 166,457 shares Expires 2029-11-14 F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 (the "Reclassification"), each share of ForgeRock, Inc.'s (the "Issuer") common stock, par value $0.001 per share (the "Common Stock"), was automatically reclassified into one share of the Issuer's Class B common stock, par value $0.001 per share (the "Class B Common Stock"), immediately prior to the closing of the initial public offering (the "IPO") of the Issuer's Class A common stock, par value $0.001 per share (the "Class A Common Stock"). Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will, subject to certain conditions and exceptions, convert automatically into one share of Class A Common Stock upon any transfer. F2 · kind: Effective upon the occurrence of the Reclassification, all stock options outstanding under the Issuer's 2012 Equity Incentive Plan (the "2012 Plan") cover shares of Class B Common Stock. F1 · price: Pursuant to a reclassification exempt under Rule 16b-7 (the "Reclassification"), each share of ForgeRock, Inc.'s (the "Issuer") common stock, par value $0.001 per share (the "Common Stock"), was automatically reclassified into one share of the Issuer's Class B common stock, par value $0.001 per share (the "Class B Common Stock"), immediately prior to the closing of the initial public offering (the "IPO") of the Issuer's Class A common stock, par value $0.001 per share (the "Class A Common Stock"). Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and has no expiration date. Additionally, each share of Class B Common Stock will, subject to certain conditions and exceptions, convert automatically into one share of Class A Common Stock upon any transfer. F3 · derivative.exercise_date: Option granted under the Issuer's 2012 Plan. One forty-eighth (1/48th) of the shares subject to the option vest each month beginning on December 14, 2019, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.